Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Germ Cell Tumors

Darren R. Feldman

达伦·费尔德曼

MD

🏢Memorial Sloan Kettering Cancer Center(纪念斯隆-凯特琳癌症中心)🌐USA

Associate Attending Physician, Genitourinary Oncology Service泌尿生殖肿瘤科副主治医师

42
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Leading expert in testicular cancer treatment and survivorship at Memorial Sloan Kettering. Specializes in the long-term health effects of GCT therapy including cardiovascular toxicity, neuropathy, hypogonadism, and second malignancies, while advancing novel therapeutic approaches for refractory disease.

Share:

🧪Research Fields 研究领域

Germ Cell Tumors生殖细胞肿瘤
Testicular Cancer睾丸癌
Cancer Survivorship癌症生存者研究

🎓Key Contributions 主要贡献

Testicular Cancer Survivorship

Conducted landmark studies on late effects of cisplatin-based therapy including cardiovascular disease, metabolic syndrome, neurotoxicity, and fertility outcomes in long-term GCT survivors.

Novel Therapeutics for Refractory GCT

Led clinical trials investigating checkpoint inhibitors, targeted therapies, and novel combinations for cisplatin-refractory GCTs, expanding options for patients failing standard salvage.

Hypogonadism and Hormone Management

Pioneered research on testosterone deficiency and its cardiovascular implications in testicular cancer survivors, establishing guidelines for hormonal monitoring and replacement.

Representative Works 代表性著作

[1]

Cardiovascular Disease Among Testicular Cancer Survivors

Journal of Clinical Oncology (2016)

Demonstrated significantly elevated cardiovascular risk in cisplatin-treated GCT survivors, prompting updated survivorship screening guidelines.

[2]

Hypogonadism in Testicular Cancer Survivors

Cancer (2014)

Characterized prevalence and clinical impact of testosterone deficiency post-GCT therapy, informing hormone replacement recommendations.

[3]

Pembrolizumab in Refractory Germ Cell Tumors

Journal of Clinical Oncology (2019)

Phase II trial of pembrolizumab showing modest but meaningful activity in heavily pretreated GCT, guiding immunotherapy investigation in this setting.

🏆Awards & Recognition 奖项与荣誉

🏆ASCO Young Investigator Award
🏆Memorial Sloan Kettering Clinical Scientist Development Award
🏆Conquer Cancer Foundation Career Development Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 达伦·费尔德曼 的研究动态

Follow Darren R. Feldman's research updates

留下邮箱,当我们发布与 Darren R. Feldman(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment